Here's What to Expect From Zimmer Biomet Holdings' Next Earnings Report

Warsaw, Indiana-based Zimmer Biomet Holdings, Inc. (ZBH) designs, manufactures, and markets effective, innovative solutions that support orthopedic surgeons and clinicians in restoring mobility, alleviating pain, and improving the quality of life for patients worldwide. With a market cap of $21.6 billion, it operates in more than 25 countries across the globe and sells products in more than 100 countries. It is expected to release its Q3 earnings before the market opens on Wednesday, Oct. 30.

Ahead of the event, analysts expect Zimmer to report a profit of $1.75 per share, up 6.1% from $1.65 per share reported in the year-ago quarter. The company has surpassed Wall Street’s adjusted EPS projections in each of the past four quarters. Its adjusted EPS for the last reported quarter grew 10.4% year-over-year to $2.01, exceeding the consensus estimates by 1.5%.